BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

  October 29, 2024

   · 

  3 min read
• 

  Inflammatory bowel disease

  Lilly and J&J Face Off in Crohn’s Disease With Phase III Readouts at ACG 2024

  Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease following approvals for ulcerative colitis. GlobalData projects total sales for Tremfya to reach $7.8 billion globally by 2029.

  October 29, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)

  October 29, 2024

   · 

  7 min read
• Press Releases

  Claritas NucMed Receives Clearance from Brazilian Regulator ANVISA to Market Claritas iPET™ Software Enabling Reduced Scan Time and Reduced Isotope Dosage in PET-CT/MRI Scans

  October 29, 2024

   · 

  3 min read
• Press Releases

  Medigene to Present at Upcoming November 2024 Investor Conferences

  October 29, 2024

   · 

  2 min read
• Press Releases

  Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting

  October 29, 2024

   · 

  1 min read
• Press Releases

  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

  October 29, 2024

   · 

  3 min read
• Press Releases

  Immunic to Participate in Industry, Scientific and Investor Conferences in November 2024

  October 29, 2024

   · 

  5 min read
• Press Releases

  Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)

  October 29, 2024

   · 

  18 min read
• Press Releases

  Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

  October 29, 2024

   · 

  19 min read